Christine Nash

Christine Nash

Director/Board Member at RALLYBIO CORPORATION

Net worth: - $ as of 2026-07-30

53 year
Health Technology
Commercial Services
Consumer Services

Profile

Christine A. Nash currently works at Rallybio Corp., as Independent Director from 2022.
Ms. Nash also formerly worked at CoTherix, Inc., as Marketing Director from 2006 to 2007, CM Group LLC, as Director from 2019 to 2022, Eli Lilly & Co., as Principal, Genesoft Pharmaceuticals, Inc., as Product Manager, Chatiemac Consulting LLC, as Principal, Oncology Therapeutics Network Corp., as Principal, Imana, Inc., as Principal, and Hyperion Therapeutics, Inc., as Chief Commercial Officer & Senior Vice President from 2012 to 2015.
Ms. Nash received her undergraduate degree and Masters Business Admin degree from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-18 0 ( -.--% ) - $ 2026-07-30

Christine Nash active positions

CompaniesPositionStart
RALLYBIO CORPORATION Director/Board Member 2022-04-03

Former positions of Christine Nash

CompaniesPositionEnd
Director/Board Member 2022-08-31
HYPERION THERAPEUTICS INC Corporate Officer/Principal 2015-04-30
Sales & Marketing 2007-01-31
Chatiemac Consulting LLC
Corporate Officer/Principal -
Imana, Inc.
Corporate Officer/Principal -
See the detail of Christine Nash's experience

Training of Christine Nash

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Distribution Services

Technology Services

Imana, Inc.

Health Technology

Chatiemac Consulting LLC

  1. Stock Market
  2. Insiders
  3. Christine Nash